Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer

3Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Most metastatic cancers develop drug resistance during treatment and continue to grow, driven by a subpopulation of cancer cells unresponsive to the therapy being administered. There is evidence that metastases are formed by phenotypically plastic cancer cells with stem-cell like properties. Currently the population structure and growth dynamics of the resulting metastatic tumors is unknown. Here, using scaling analysis of clinical data of tumor burden in patients with metastatic prostate cancer, we show that the drug resistant, metastasis-causing cells (MCC) are capable of producing drug resistant, exponentially growing tumors, responsible for tumor growth as a patient receives different treatments.

Cite

CITATION STYLE

APA

Blagoev, K. B., Iordanov, R., Zhou, M., Fojo, T., & Bates, S. E. (2021). Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer. Oncotarget, 11(22), 15–21. https://doi.org/10.18632/ONCOTARGET.27855

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free